E-LIB Suche - Ergebnisse für: Giles, I.

1

Comparativa de resultados obstétricos en pacientes con lupu..:

Muñoz Muñoz, C. ; Farinha, F. ; McDonnell, T....
Revista Clínica Española. 224 (2024) 6 - p. 357-365 , 2024

Link: https://doi.org/10.1016/..

2

Outcomes following biosimilar TNF inhibitor use for inflamm..:

Scott, R ; Parker, H ; Mccartney, S...
Obstetric Medicine. 15 (2021) 2 - p. 104-107 , 2021

Link: https://doi.org/10.1177/..

3

Domain I of β2GPI is capable of blocking serum IgA antiphos..:

Albay, A ; Artim-Esen, B ; Pericleous, C...
Lupus. 28 (2019) 7 - p. 893-897 , 2019

Link: https://doi.org/10.1177/..

4

Proof-of-concept study demonstrating the pathogenicity of a..:

Pericleous, C. ; Ruiz-Limon, P. ; Romay-Penabad, Z....
Rheumatology. 54 (2014) 4 - p. 722-727 , 2014

Link: https://doi.org/10.1093/..

5

Cardiovascular Risk Factors in Women With Primary Sjögren's..:

Juarez, M. ; Toms, T. E. ; de Pablo, P....
Arthritis Care & Research. 66 (2014) 5 - p. 757-764 , 2014

Link: https://doi.org/10.1002/..

6

Do the EULAR Sjogren's syndrome outcome measures correlate ..:

Lendrem, D. ; Mitchell, S. ; McMeekin, P....
Rheumatology. 54 (2014) 4 - p. 655-659 , 2014

Link: https://doi.org/10.1093/..

7

Oral Abstracts 1: Connective Tissue Disease * O1. Long-Term..:

Gayed, M. ; Leone, F. ; Toescu, V....
Rheumatology. 52 (2013) suppl 1 - p. i26-i32 , 2013

Link: https://doi.org/10.1093/..

8

Soluble molecule profiling and network analysis of primary ..:

Tarn, JR ; Natasari, A ; Mitchell, S...
BMC Musculoskeletal Disorders. 14 (2013) S1 - p. , 2013

Link: https://doi.org/10.1186/..

9

Within‐patient variation of hemoglobin and reticulocytes: i..:

Van Wyck, D. B. ; Giles, I. ; Sharpe, K.
International Journal of Laboratory Hematology. 34 (2012) 6 - p. 577-583 , 2012

Link: https://doi.org/10.1111/..

10

The efficacy of repeated treatment with B-cell depletion th..:

Turner-Stokes, T. ; Lu, T. Y. ; Ehrenstein, M. R....
Rheumatology. 50 (2011) 8 - p. 1401-1408 , 2011

Link: https://doi.org/10.1093/..

11

SLE and Antiphospholipid Syndrome [223-231]: 223. Acid Disr..:

Morgan, M. D. ; Burke, F. ; Biela, C....
Rheumatology. 49 (2010) Supplement 1 - p. i119-i122 , 2010

Link: https://doi.org/10.1093/..

12

Miscellaneous Rheumatic Diseases [73-83]: 73. Is There a De..:

Mannan, E. ; Reddy, V. ; Pearce, C....
Rheumatology. 49 (2010) Supplement 1 - p. i61-i64 , 2010

Link: https://doi.org/10.1093/..

13

In vivoinhibition of antiphospholipid antibody-induced path..:

IOANNOU, Y. ; ROMAY-PENABAD, Z. ; PERICLEOUS, C....
Journal of Thrombosis and Haemostasis. 7 (2009) 5 - p. 833-842 , 2009

Link: https://doi.org/10.1111/..

14

Are endothelial microparticles potential markers of vascula..:

Pericleous, C ; Giles, I ; Rahman, A
Lupus. 18 (2009) 8 - p. 671-675 , 2009

Link: https://doi.org/10.1177/..

15

Autoantibodies and other biomarkers – pathological conseque..:

Giles, I ; Putterman, C
Lupus. 17 (2008) 3 - p. 241-246 , 2008

Link: https://doi.org/10.1177/..